Physician profile
Thomas Hanff
NPI 1578867370
$8,257.16
in general payments reported to CMS, 2019-2025
9 companies · $3,119 in 2025
The $3,119 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $34.41 · 2022: $158 · 2023: $38.96 · 2024: $3,773 · 2025: $3,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,550 · Consulting Fee: $2,400 · Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,550.00 |
| Consulting Fee | $2,400.00 |
| Food and Beverage | $980.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $3,649.01 | 2024-2025 | Giapreza |
| Cvrx, INC. | $2,400.00 | 2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $984.65 | 2019 | |
| Abbott Laboratories | $745.88 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Freestyle Libre 2 |
| Shockwave Medical, INC | $189.39 | 2025 | |
| Paragonix Technologies, INC. | $160.04 | 2024 | |
| Boston Scientific Corporation | $95.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $21.22 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hanff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.